Expression of vascular endothelial growth factors (VEGF-A/VEGF-1 and VEGF-C/VEGF-2) in postmenopausal uterine endometrial carcinoma

Gynecologic Oncology

Volumn 80, Issue 2, 2001, Pages 181-188

  Hirai, M ^a   Nakagawara, A ^a   Oosaki, T ^a   Hayashi, Y ^a   Hirono, M ^a   Yoshihara, T ^a  

^a CHIBA CANCER CENTER   (Japan)

Author keywords

Endometrial carcinoma; Lymphatic invasion; Vascular invasion; VEGF A; VEGF C

Indexed keywords

UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN 1; VASCULOTROPIN A; VASCULOTROPIN C;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER INVASION; CANCER SURVIVAL; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VASCULARIZATION;

EID: 0035136974     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2000.6056     Document Type: Article

References (33)

1. What is the evidence that tumors are angiogenesis dependent?
2. Distribution of vascular permeability factor (vascular endotherial growth factor) in tumors: Correlation in tumor blood vessels
3. Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma
4. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
5. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas
6. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma
7. Hyperplasia of lymphatic vessels in VEGF-C/VEGF-2 transgenic mice
8. Epidermal growth factor receptor expression in normal and malignant endometrium
9. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of gastrointestinal tract
10. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma
11. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia
12. Vascular endothelial growth factor and the endometrium
13. Angiogenesis, vascular endothelial growth factor and the endometrium
14. Angiogenesis in malignancies of the female genital tract
15. Prognostic factors relating to survival in uterine endometrial carcinoma
16. Relationship between surgical pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study
17. Lymphvascular space involvement - A prognostic indicator in endometrial adenocarcinoma
18. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas
19. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis
20. Inhibition of vascular endothelial growth factor-induced angiogenesis suppress tumour growth in vivo
21. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
22. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: Rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth
23. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis
24. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids
25. Angiogenesis in endometrial hyperplasia and stage I endometrial carcinoma
26. The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients
27. Tumor angiogenesis in advanced stage ovarian carcinoma
28. VEGF, flt-l, and KDR/flk-1 as prognostic indicators in endometrial carcinoma
29. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia
30. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors
31. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer
32. Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer